Glucose Braun (Glucose)

Glucose Braun is employed in clinical settings to supply immediate carbohydrate calories and help maintain fluid balance. Typical applications include:

• Treatment of acute hypoglycemia when oral intake is not possible
• Peri‑operative fluid replacement to support energy needs
• Nutritional support for patients receiving enteral or parenteral therapy
• Dilution medium for compatible intravenous medications
• Adjunct to electrolyte solutions for balanced resuscitation

Glucose Braun may be associated with a range of adverse reactions, most of which are related to the intravenous administration of a carbohydrate solution.

Common

• Mild hyperglycemia or transient rise in blood glucose
• Local irritation at the infusion site
• Nausea or mild gastrointestinal discomfort
• Headache or dizziness during rapid infusion
• Electrolyte shifts such as mild hyponatremia
• Transient increase in serum osmolality

Serious

• Severe hyperglycemia leading to osmotic diuresis
• Allergic or anaphylactoid reaction (rash, urticaria, bronchospasm)
• Volume overload or pulmonary edema in susceptible patients
• Metabolic acidosis in cases of massive infusion
• Hyperosmolar hyperglycemic state in diabetic individuals
• Sepsis or infection related to contaminated infusion equipment

When using Glucose Braun, healthcare providers should observe several safety considerations to reduce risk:

• Verify patient blood‑glucose level before and during infusion, especially in diabetic or critically ill patients
• Adjust infusion rate in patients with impaired renal or cardiac function to avoid fluid overload
• Use aseptic technique to prevent contamination of the solution
• Monitor electrolytes, particularly sodium and potassium, as glucose infusion can affect their balance
• Avoid rapid bolus administration unless specifically indicated
• Document the concentration and total volume administered in the patient record
• Ensure compatibility with other intravenous drugs before co‑administration

Glucose Braun can interact with other medications or clinical conditions, requiring careful assessment.

Avoid

• Co‑administration with insulin or other hypoglycemic agents without adjusting doses, as this may precipitate severe hypoglycemia
• Mixing with calcium‑containing solutions that may precipitate insoluble salts
• Use in patients with known severe hyperglycemia or uncontrolled diabetes without medical supervision

Use with caution

• Concurrent administration of diuretics that may alter fluid and electrolyte status
• Beta‑blockers, which can mask symptoms of hypoglycemia
• Corticosteroids, which can increase blood‑glucose levels
• Parenteral nutrition regimens that already contain carbohydrate calories
• Medications that affect renal function, requiring close monitoring of fluid balance